Furthermore, genomic analyses of MASH-related HCC cohorts have identified somatic mutations in key pathway components, including activating mutations in PIK3CA and loss-of-function mutations in the tumor suppressor PTEN 34. The gene discussed is PIK3CA; the disease is hepatocellular carcinoma.